Beijing: China on Saturday said it has given conditional approval for Pfizer’s COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.
The National Medical Products Administration said further research on the drug needed to be undertaken and submitted to the regulator.
Paxlovid has so far been authorized in several countries including the United States and Israel, while the European Union has permitted member states to use it ahead of formal approval as an emergency measure against Omicron.
Unlike Covid-19 vaccines, the drug does not target the ever-evolving spike protein that the coronavirus uses to invade cells.
China, where the coronavirus first emerged in late 2019, has not approved any foreign-made vaccines against Covid-19.
Comments are closed.